Cong-Li Zhang

Bortezomib-based chemotherapy reduces early mortality and improves outcomes in patients with ultra-high-risk light-chain amyloidosis: a retrospective case control study

Kaini Shen, Cong-Li Zhang, Zhuang Tian et al. · Amyloid · 2019 · 23 citations

Medicine, Oncology, Pharmacology +13

Clinical characteristics and treatment outcome of type I cryoglobulinemia in Chinese patients: a single-center study of 45 patients

Lele Zhang, Xinxin Cao, Kaini Shen et al. · Annals of Hematology · 2020 · 22 citations

Medicine, Hematology, Internal Medicine +6

Differential expression of endocannabinoid system-related genes in the dorsal hippocampus following expression and reinstatement of morphine conditioned place preference in mice

Wei Li, Cong-Li Zhang, Zhengguo Qiu · Neuroscience Letters · 2017 · 16 citations

Life Sciences, Neurobiology, Neuroscience +17

Genomic profiling in amyloid light-chain amyloidosis reveals mutation profiles associated with overall survival

Xufei Huang, Junliang Lu, Kaini Shen et al. · Amyloid · 2019 · 15 citations

Life Sciences, Genetics, Molecular Genetics +17

Posttreatment dFLC less than 10 mg/L predicts superior organ response and longer time to next treatment in newly diagnosed light-chain amyloidosis patients treated with bortezomib

Kaini Shen, Cong-Li Zhang, Jun Feng et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2020 · 14 citations

Medicine, Oncology, Pharmacotherapy +15